Exclusive

Publication

Byline

US Patent Issued to SHANGHAI GENBASE BIOTECHNOLOGY on May 19 for "Anti-CLDN18.2 antibody and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,626, issued on May 19, was assigned to SHANGHAI GENBASE BIOTECHNOLOGY Co. LTD. (Shanghai). "Anti-CLDN18.2 antibody and uses thereof" was inv... Read More


US Patent Issued to INNOVENT BIOLOGICS (SUZHOU), BEIJING HANMI PAHRMACEUTICAL on May 19 for "Formulation comprising anti-PD-1/HER2 bispecific antibody, method for preparing same and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,627, issued on May 19, was assigned to INNOVENT BIOLOGICS (SUZHOU) Co. LTD. (Suzhou, China) and BEIJING HANMI PAHRMACEUTICAL Co. LTD. (Beijin... Read More


US Patent Issued to Agenus on May 19 for "Anti-TIGIT antibodies and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,628, issued on May 19, was assigned to Agenus Inc. (Lexington, Mass.). "Anti-TIGIT antibodies and methods of use thereof" was invented by Ol... Read More


US Patent Issued to Wellmarker Bio on May 19 for "Anti-IGSF1 antibody and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,629, issued on May 19, was assigned to Wellmarker Bio Co. Ltd. (Seoul, South Korea). "Anti-IGSF1 antibody and use thereof" was invented by S... Read More


US Patent Issued to Shanghai Henlius Biotech, Shanghai Henlius Biopharmaceutical, Shanghai Henlius Biologics on May 19 for "Anti-CD47 antibodies and methods of use" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,630, issued on May 19, was assigned to Shanghai Henlius Biotech Inc. (Shanghai), Shanghai Henlius Biopharmaceutical Co. Ltd. (Shanghai) and S... Read More


US Patent Issued to ACTICOR BIOTECH, UNIVERSITE PARIS CITE, UNIVERSITE PARIS-XIII, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS-SACLAY on May 19 for "Inhibition of platelet aggregation using anti- human gpvi antibodies" (French Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,631, issued on May 19, was assigned to ACTICOR BIOTECH (Paris), UNIVERSITE PARIS CITE (Paris), UNIVERSITE PARIS-XIII (Villetaneuse, France), ... Read More


US Patent Issued to Memorial Sloan Kettering Cancer Center on May 19 for "Bispecific HER2 and CD3 binding molecules" (New York Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,632, issued on May 19, was assigned to Memorial Sloan Kettering Cancer Center (New York). "Bispecific HER2 and CD3 binding molecules" was in... Read More


US Patent Issued to Novartis on May 19 for "Antibody molecules to PD-1 and uses thereof" (Iowa, Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,633, issued on May 19, was assigned to Novartis AG (Basel, Switzerland). "Antibody molecules to PD-1 and uses thereof" was invented by Sanel... Read More


US Patent Issued to ETABLISSEMENT FRANCAIS DU SANG on May 19 for "Recombinant full-length single chain immunoglobulins" (French Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,634, issued on May 19, was assigned to ETABLISSEMENT FRANCAIS DU SANG (Saint Denis, France). "Recombinant full-length single chain immunoglo... Read More


US Patent Issued to Ventana Medical Systems on May 19 for "Polynucleotides encoding anti-PD-L1 antibodies" (California, Arizona Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,635, issued on May 19, was assigned to Ventana Medical Systems Inc. (Tucson, Ariz.). "Polynucleotides encoding anti-PD-L1 antibodies" was in... Read More